
Miss World Crowns Business Tycoon Sudha Reddy As Its Maiden Global Ambassador
Sudha Reddy, Chairperson of the Sudha Reddy Foundation and Director of MEIL, was named Global Ambassador for the Miss World Organisation at the 72nd Miss World Festival finale. This appointment marks the organisation's first global ambassadorship and acknowledges Reddy's work in social impact, humanitarian efforts, and equitable development.
As Global Ambassador for Beauty With A Purpose, the charitable arm of the Miss World Organisation, Reddy will contribute to global outreach efforts and projects in various countries. Her contributions will include promoting humanitarian initiatives and highlighting narratives from across the globe, aiming to support the organization's impact.
Reddy also served on the jury for the Miss World 2025 Grand Finale, offering her perspective to the selection of the titleholder.
Prior to the main event, Reddy organised the Beauty With A Purpose Gala, which brought together 108 contestants at her estate, Mon Amour Palais. The gala's broadcast in Times Square, New York, highlighted a notable moment for Telangana.
Sudha Reddy, who wore a Tarun Tahiliani traditional ensemble for the event, commented, 'To the Miss World Organisation, to Julia Morley, and to everyone sharing this evening: Vanakkam. From Hyderabad, the heart of Telangana, I am grateful to stand before you. This honour is a testament to the power of compassion, the force of love, and the potential of selfless giving – values that resonate with my home state. Like the intricate designs of a Bidri artwork, my life has been shaped by a profound belief in Vasudhaiva Kutumbakam – the world is one family. This ancient wisdom encourages me to offer support to those in need, regardless of borders or background. It is with this spirit that I embrace the role of a Global Ambassador. My pledge is simple: to channel the spirit of seva into every endeavour. To highlight stories of hope, resilience and unwavering humanity that exist in every corner of our world. To the young people who are the inheritors of this world, and to everyone committed to creating a more just and compassionate future: consider the power of a single act of kindness. Consider the ability of love to heal, to unite and to transform. Let compassion be your compass, philanthropy your guide, and love the force that propels you forward. For in giving, we receive. In loving, we are loved. And in serving others, we truly find ourselves.'
Julia Morley, Chairperson and Founder of the Miss World Organization, presented the award and acknowledged Reddy's commitment and contribution to humanitarian work.
Sudha Reddy has been a philanthropist, industrialist and cultural ambassador, serving as the director of Megha Engineering & Infrastructures Limited (MEIL), an infrastructure conglomerate headquartered in Hyderabad. Under her leadership, MEIL has worked across various sectors and supported corporate social responsibility through community development initiatives and wellness programs benefiting the Hyderabad region and beyond.
Additionally, Reddy chairs the Sudha Reddy Foundation, a philanthropic organisaation focused on education and empowering of marginalised groups. The Foundation has formed partnerships with organisations such as UNICEF and the Global Gift Foundation to extend its reach. Her involvement in global causes was also reflected in her noted appearances at prestigious international events, including the Met Gala, the Paris Olympics, and the Cannes Film Festival, where she has represented Indian culture and philanthropy. The work of the Sudha Reddy Foundation and MEIL Group in Hyderabad has focused on improving lives and supporting sustainable development within the community.
Note to the reader: This article is part of Hindustan Times' paid consumer connect initiative and is independently created by the brand. Hindustan Times assumes no editorial responsibility for the content.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
3 hours ago
- Time of India
Dr Reddy's, Alvotech join hands to co-develop, manufacture & commercialise biosimilar of Merck's blockbuster drug Keytruda
Dr Reddy's, Alvotech join hands to co-develop, manufacture & commercialise biosimilar of Merck's blockbuster drug Keytruda HYDERABAD: Dr Reddy's Laboratories has entered into a collaboration and license agreement with Iceland-based biotech player Alvotech for the co-development, manufacturing and commercialiation of a biosimilar of Merck Sharp & Dohme's blockbuster drug Keytruda (pembrolizumab). Keytruda, which is used for the treatment of various types of cancer, clocked sales of over US$29.5 billion in 2024. The collaboration will combine Dr Reddy's and Alvotech's capabilities in biosimilars to speed up the development process and extend the global reach of the biosimilar candidate. As per the agreement, the two companies will share the costs and responsibilities for jointly developing and manufacturing the biosimilar candidate and subject to certain exceptions, each company will have the right to commercialise the product globally, Dr Reddy's said on Thursday. 'The agreement demonstrates Alvotech's ability to leverage its dedicated R&D and manufacturing platform for biosimilars, accelerating the expansion of our pipeline by pursuing growing global markets. It further enables us to increase the availability of cost-effective, critical biologic medications to patients worldwide,' said Róbert Wessman, chairman & CEO, Alvotech. Dr Reddy's CEO, Erez Israeli, said the pact demonstrates the company's ability to develop and manufacture high-quality and affordable treatment options for patients worldwide. 'Oncology has been a top focus therapy area for us, and this collaboration will further enhance our capabilities in oncology, as pembrolizumab currently represents one of the most critical therapies in immuno-oncology,' Israeli added. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
&w=3840&q=100)

Business Standard
5 hours ago
- Business Standard
Dr Reddy's, Alvotech to co-develop biosimilar of cancer drug Keytruda
Global biotech major Alvotech and Hyderabad-based Dr Reddy's Laboratories (DRL) have entered into a collaboration to co-develop, manufacture, and commercialise a biosimilar version of Merck's blockbuster cancer drug Keytruda (pembrolizumab), which recorded global sales of $29.5 billion in 2024. Shares of DRL rose 3 per cent on Thursday on the BSE following the announcement. Under the agreement, both parties will jointly manage development and manufacturing responsibilities, while sharing associated costs. Each company will also hold global commercialisation rights, subject to certain exceptions. Keytruda, developed by Merck & Co., is used to treat a wide range of cancers, including lung, melanoma, and head and neck cancers. With patents for Keytruda expected to expire in major markets over the next few years, competition among biosimilar developers is intensifying. The partnership is a strategic boost to Dr Reddy's oncology portfolio—a key therapeutic area for the company—and significantly expands Iceland-based Alvotech's biosimilar pipeline. The tie-up comes amid growing global demand for cost-effective biologic alternatives in cancer care, especially in immuno-oncology, where Keytruda remains a dominant therapy. 'We are happy to collaborate with Alvotech for the pembrolizumab biosimilar,' said Erez Israeli, CEO of Dr Reddy's. 'Oncology has been a top focus therapy area for us, and this collaboration further enhances our capabilities.' Alvotech Chairman and CEO Róbert Wessman said the partnership would accelerate development while broadening global access to critical biologics. 'This agreement demonstrates our ability to leverage our R&D and manufacturing platform to pursue growing global markets,' he said. Alvotech, listed on Nasdaq, is focused solely on biosimilars and already has approvals for adalimumab and ustekinumab biosimilars. Its pipeline includes candidates for autoimmune, respiratory, and oncologic indications. Dr Reddy's, which has commercialised six biosimilars in India and over 30 countries, has been scaling up global biologics operations. It launched its first biosimilar in the UK—Versavo (bevacizumab)—in 2024, and pegfilgrastim in the US and Europe through partners. With this collaboration, both companies aim to play a larger role in shaping the next phase of affordable cancer care globally.


Economic Times
8 hours ago
- Economic Times
Want to live longer? Forget expensive experiments; longevity doctor reveals simple secrets to a healthier, happier life
Longevity doctor Dr. Avinish Reddy believes living a longer, healthier life is rooted in simple, consistent habits. From daily strength and cardio workouts to prioritizing social connections and brain health, his approach avoids extremes. (Images: LinkedIn/Avinish Reddy, iStock) In a world obsessed with stories of Bryan Johnson's biohacking with high-tech health fixes, Dr. Avinish Reddy is bringing longevity back to the basics. His message is refreshingly clear: living a long, healthy life doesn't have to be complicated. After years of studying under world-renowned longevity expert Dr. Peter Attia and launching his own practice, Elevated Medical, in July 2024, Dr. Reddy has distilled the science of longevity into an accessible, holistic routine—one he practices daily. According to a report from CNBC Make It , with a framework that spans medicine, exercise, nutrition, and lifestyle, Dr. Reddy's philosophy is grounded in structure, consistency, and self-awareness rather than fads or extreme measures. His methods are not just for patients—they are part of his own lived experience. At the heart of Dr. Reddy's approach is movement. He splits his weekly workouts evenly between strength and cardiovascular training, not just for muscle or aesthetics but to boost VO₂ Max—an often-overlooked metric linked to better health span and life span. His cardio routine includes both low-intensity endurance and high-intensity intervals, a strategy shown to be deeply effective for heart and brain health. But fitness is only one piece. Reddy also prioritizes brain health through a regimen of omega-3s and B vitamins, while engaging in mentally stimulating activities like racket sports. Table tennis, pickleball, and tennis aren't just hobbies—they're preventive tools in his longevity arsenal. Eventually, he plans to learn a language or an instrument, tapping into deeper neuroplastic benefits. While many obsess over diet and sleep trackers, Reddy emphasizes something most wellness plans overlook: social connection. Citing the long-running Harvard study on happiness, he underscores that strong relationships—whether daily calls to his parents or reconnecting with old friends—are just as critical to longevity as exercise and nutrition. He also encourages community-based activities, like joining a local sports league, as a way to merge social bonding with physical activity. His patients, especially older ones, often seek recovery not to hit the gym again but to return to the social joys of golf groups or pickleball teams. That, he says, is the real magic. When it comes to food, Reddy believes less in chasing macros and more in correcting personal nutritional blind spots. For him, it's all about vegetables—making sure they're on his plate at every meal. He even uses a continuous glucose monitor annually to identify hidden dietary culprits that might spike his blood sugar. And perhaps most surprising for a longevity doctor, his favorite book isn't about health—it's Die With Zero by Bill Perkins. It's a manifesto for living fully, not just longer. 'Longevity shouldn't come at the cost of living,' Reddy reflects. 'What's the point of making it to 100 if you never made the memories?' Dr. Reddy's life is a masterclass in sustainable living—not by perfection, but by thoughtful, balanced habits. His philosophy pushes back against extreme health culture. It's not about chasing the next miracle cure; it's about doing the basics well, every single day. For anyone overwhelmed by the noise of the wellness industry, his message is a breath of fresh air: longevity isn't about making things harder—it's about living smarter.